Position in BBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$741,017,831
-$138,401,317 QoQ
Shares Held
9,949,219
-16.0% QoQ
Ownership
5.09%
of shares outstanding
% of Portfolio
2.15%
of 13F equity value
Holder Rank
#5
of 472 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VIKING GLOBAL INVESTORS LP holds $2,489,856,848 across 17 Biotechnology names. BBIO ranks #1 (29.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
This page
|
9,949,219 | $741,017,831 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
7,616,563 | $435,819,734 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
6,271,467 | $221,947,217 | |
| 4 | MANE |
Veradermics, Inc
|
1,561,494 | $191,970,072 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
1,503,478 | $143,086,001 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
4,203,567 | $142,458,885 | |
| 7 | SION |
Sionna Therapeutics, Inc.
|
3,195,181 | $140,556,012 | |
| 8 | PHVS |
Pharvaris N.V.
|
3,653,310 | $126,331,459 |
All Filings in BBIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $741,017,831 | 9,949,219 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $879,419,148 | 11,842,434 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,100,992,011 | 14,393,934 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $829,889,477 | 15,977,849 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $801,221,092 | 18,555,375 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $762,454,313 | 22,055,375 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $689,319,993 | 25,120,991 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $639,580,430 | 25,120,991 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $636,314,702 | 25,120,991 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $776,741,041 | 25,120,991 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,014,134,406 | 25,120,991 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $662,440,532 | 25,120,991 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $457,881,045 | 26,620,991 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $441,376,030 | 26,620,991 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $202,851,951 | 26,620,991 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $264,612,650 | 26,620,991 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $241,718,598 | 26,620,991 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $270,203,058 | 26,620,991 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $444,038,129 | 26,620,991 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $1,247,725,848 | 26,620,991 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 | $1,622,815,611 | 26,620,991 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,639,853,045 | 26,620,991 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,893,018,670 | 26,620,991 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $998,819,582 | 26,620,991 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $868,110,516 | 26,620,991 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $772,008,739 | 26,620,991 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||